These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3477190)

  • 1. Nisoldipine, a new calcium antagonist, elevates plasma levels of digoxin.
    Kirch W; Stenzel J; Santos SR; Ohnhaus EE
    Arch Toxicol Suppl; 1987; 11():310-2. PubMed ID: 3477190
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.
    Pasanisi F; Meredith PA; Reid JL
    Eur J Clin Pharmacol; 1985; 29(1):21-4. PubMed ID: 4054203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.
    Kirch W; Stenzel J; Dylewicz P; Hutt HJ; Santos SR; Ohnhaus EE
    Br J Clin Pharmacol; 1986 Aug; 22(2):155-9. PubMed ID: 3530303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the haemodynamic effects of nifedipine, nisoldipine and nitrendipine in man.
    Debbas NM; Jackson SH; Turner P
    Eur J Clin Pharmacol; 1986; 30(4):393-7. PubMed ID: 2943594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nisoldipin: a vasoselective calcium antagonist].
    Fortschr Med Suppl; 1987; 30():1-22. PubMed ID: 2884178
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute effects of nisoldipine in patients with stable effort angina].
    De Caprio L; Acanfora D; Papa M; Gallucci F; Leosco D; Covelluzzi F; Borgnino C; Cicatiello M; Cosentino F; Rengo F
    Cardiologia; 1988 Oct; 33(10):985-8. PubMed ID: 3069205
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of nisoldipine on left ventricular function during exercise or cold pressor stress.
    Dymond DS; Caplin JL; O'Keefe JC; Banim S
    Eur Heart J; 1987 Nov; 8 Suppl K():27-33. PubMed ID: 3450520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina.
    Crean PA; Waters DD; Lam J; Chaitman BR
    Am Heart J; 1987 Feb; 113(2 Pt 1):261-5. PubMed ID: 3544754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the comparative coronary vasodilator, vasodepressor and antiarrhythmic actions of gallopamil (D-600) and nisoldipine (Bay K 5552).
    Basu DK; Brahmankar DM
    Mater Med Pol; 1985; 17(2):103-6. PubMed ID: 4079466
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
    Levine MA; Ogilvie RI; Leenen FH
    Clin Pharmacol Ther; 1988 Jan; 43(1):39-48. PubMed ID: 2826066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous nisoldipine in severe congestive heart failure.
    Moe GW; Karlinsky SJ; Frankel D; Armstrong PW
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):160-6. PubMed ID: 2459547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T; Hartling OJ; Kelbaek H; Nielsen SL
    Eur J Clin Pharmacol; 1986; 31(4):387-9. PubMed ID: 3816916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
    Knorr A
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):141-50. PubMed ID: 7165419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
    Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of nisoldipine on left ventricular filling rate in patients with ischemic heart disease measured with radionuclide gated blood pool scintigraphy.
    Otto AC; van Aswegen A; Herbst CP; Sweetlove MA; Viviers AC; Flint GR
    Eur J Nucl Med; 1988; 14(11):542-5. PubMed ID: 3061821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.
    Francis JL; Roath OS; Challenor VF; Waller DG
    Br J Clin Pharmacol; 1988 Jun; 25(6):751-4. PubMed ID: 3203045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and hemodynamic effects of long-term nisoldipine treatment in hypertensive patients.
    van Harten J; van Brummelen P; Danhof M; Quekel RP; Breimer DD
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):624-9. PubMed ID: 2471001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nisoldipine in primary Raynaud's phenomenon.
    Challenor VF; Waller DG; Francis DA; Francis JL; Mani R; Roath S
    Eur J Clin Pharmacol; 1987; 33(1):27-30. PubMed ID: 3691593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin plasma concentrations and nifedipine.
    Belz GG; Aust PE; Munkes R
    Lancet; 1981 Apr; 1(8224):844-5. PubMed ID: 6111709
    [No Abstract]   [Full Text] [Related]  

  • 20. Voltage clamp comparison of the organic calcium channel blockers D-600 and nisoldipine.
    Uehara A; Hume JR
    Proc West Pharmacol Soc; 1984; 27():343-7. PubMed ID: 6494173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.